Go for the gold during Hoxworth’s Platelet Olympics event
Make four platelet donations between Feb. 1 and March 31 to earn a medal and special gift
Hoxworth Blood Center, University of Cincinnati, invites donors to “go for the gold” in the Hoxworth Winter Platelet Olympics.
Individuals who donate platelets four times between Feb. 1 and March 31 will win the title of “gold medalist” and receive an exclusive Hoxworth-branded camping chair and a gold medal.
“Platelets are an incredibly important component of blood — they are essential for blood clotting, and critical for patients undergoing organ transplants and treatment for cancer,” said Alecia Lipton, Hoxworth spokesperson. “Because platelets have a shelf life of just five to seven days, Hoxworth has an ongoing need for dedicated platelet donors.”
According to Lipton, blood banks across the country have issued pleas for blood and platelet donors as the national blood supply has dwindled in recent weeks; the need is only expected to increase through the winter months.
“Without our donors, we cannot provide lifesaving blood products to the area hospitals we serve,” Lipton said. “We need the Cincinnati community to make platelet donation a priority so we can keep our shelves stocked for patients during these difficult winter months.”
Appointments for platelet donations are highly encouraged.
For more information, call Hoxworth at (513) 451-0910, or schedule a donation.
About Hoxworth Blood Center
Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.